ABOUT US
CONTACT US
FAQ
PRIVACY POLICY
REFUND AND CANCELLATION
BLOGS
COMPANIES
REPORTS
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative
0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Sodium Iodide 131 Therapeutic Capsule Market Outlook, In‑Depth Analysis & Forecast to 2031
Published Date: November 2025
|
Report Code: QYRE-Auto-11W17388
Home | Market Reports | Business & Industrial| Pharmaceuticals & Biotech
Global Sodium Iodide 131 Therapeutic Capsule Market Research Report 2024
BUY CHAPTERS

Global Sodium Iodide 131 Therapeutic Capsule Market Outlook, In‑Depth Analysis & Forecast to 2031

Code: QYRE-Auto-11W17388
Report
November 2025
Pages:150
QYResearch
Buy Now with 15% Discount
DESCRIPTION
TABLE OF CONTENT
TABLES & FIGURES
FEATURED COMPANIES
ANSTO
PDRadiopharma Inc.
China Isotope & Radiation Corporation (CIRC)
International Isotopes Inc.
Curium Pharma
Jubilant Pharmova
POLATOM（NCBJ）
NTP Radioisotopes
Isotope JSC (ROSATOM)
China Isotope & Radiation Corporation (CIRC)

Sodium Iodide 131 Therapeutic Capsule Market Size

The global Sodium Iodide 131 Therapeutic Capsule market is projected to grow from US$ 142 million in 2024 to US$ 271 million by 2031, at a CAGR of 9.8% (2025-2031), driven by critical product segments and diverse end‑use applications, while evolving U.S. tariff policies introduce trade‑cost volatility and supply‑chain uncertainty.

Sodium Iodide 131 Therapeutic Capsule Market

Sodium Iodide 131 Therapeutic Capsule Market

The global market for Sodium Iodide-131 therapeutic capsules is relatively niche but is expected to grow steadily due to the increasing incidence of thyroid disorders, advancements in nuclear medicine technology, and expanding applications of I-131 therapy.

Report Includes:

This definitive report equips CEOs, marketing directors, and investors with a 360° view of the global Sodium Iodide 131 Therapeutic Capsule market, seamlessly integrating production and sales performance across the value chain. It analyzes historical sales volume and revenue sales data (2020–2024) and delivers forecasts through 2031, illuminating demand trends and growth drivers.
By segmenting the market by Type and by Application, the study quantifies volume and value, growth rates, technical innovations, niche opportunities, and substitution risks, and analyzes downstream customers distribution pattern.
Granular regional insights cover five major markets—North America, Europe, APAC, South America, and MEA—with in‑depth analysis of 20+ countries. Each region’s dominant products, competitive landscape, and downstream demand trends are clearly detailed.
Critical competitive intelligence profiles manufacturers—sales volume, revenue, margins, pricing strategies, and major customers—and dissects the top-player positioning across product lines, applications, and regions to reveal strategic strengths.
A concise supply‑chain overview maps upstream suppliers, manufacturing technologies, cost structures, and distribution dynamics to identify strategic gaps and unmet demand.
Market Segmentation

Scope of Sodium Iodide 131 Therapeutic Capsule Market Report

Report Metric Details
Report Name Sodium Iodide 131 Therapeutic Capsule Market
Accounted market size in 2024 US$ 142 million
Forecasted market size in 2031 US$ 271 million
CAGR 9.8%
Base Year 2024
Forecasted years 2025 - 2031
Segment by Type
  • 37-7400 MBq/ Capsule
  • 7400MBq-/ Capsule
Segment by Application
  • Thyroid Cancer Treatment
  • Hyperthyroidism Treatment
Sales by Region
  • North America (United States, Canada)
  • Europe (Germany, France, UK, Italy, Russia) Rest of Europe
  • Nordic Countries
  • Asia-Pacific (China, Japan, South Korea)
  • Southeast Asia (India, Australia)
  • Rest of Asia
  • Latin America (Mexico, Brazil)
  • Rest of Latin America
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)
By Company ANSTO, PDRadiopharma Inc., China Isotope & Radiation Corporation (CIRC), International Isotopes Inc, Curium Pharma, Jubilant Pharmova, POLATOM（NCBJ）, NTP Radioisotopes, Isotope JSC (Rosatom)
Forecast units USD million in value
Report coverage Revenue and volume forecast, company share, competitive landscape, growth factors and trends

Chapter Outline

  • Chapter 1: Defines the Sodium Iodide 131 Therapeutic Capsule study scope, segments the market by Type and by Application, etc, highlights segment size and growth potential.
  • Chapter 2: Offers current market state, projects global revenue and sales to 2031, pinpointing high consumption regions and emerging market catalysts
  • Chapter 3: Dissects the manufacturer landscape—ranks by volume and revenue, analyzes profitability and pricing, maps production bases, details manufacturer performance by product type and evaluates concentration alongside M&A moves.
  • Chapter 4: Unlocks high margin product segments—compares sales, revenue, ASP, and technology differentiators, highlighting growth niches and substitution risks
  • Chapter 5: Targets downstream market opportunities—evaluates sales, revenue, and pricing by Application, identifies emerging use cases, and profiles leading customers by region and by Application.
  • Chapter 6: North America—breaks down sales and revenue by Type, by Application and country, profiles key manufacturers and assesses growth drivers and barriers.
  • Chapter 7: Europe—analyses regional sales, revenue and market by Type, by Application and manufacturers, flagging drivers and barriers.
  • Chapter 8: Asia Pacific—quantifies sales and revenue by Type, by Application, and region/country, profiles top manufacturers, and uncovers high potential expansion areas.
  • Chapter 9: Central & South America—measures sales and revenue by Type, by Application, and country, profiles top manufacturers, and identifies investment opportunities and challenges.
  • Chapter 10: Middle East and Africa—evaluates sales and revenue by Type, by Application, and country, profiles key manufacturers, and outlines investment prospects and market hurdles
  • Chapter 11: Profiles manufacturers in depth—details product specs, sales, revenue, margins; Top manufactures 2024 sales breakdowns by Product type, by Application, by sales region SWOT analysis, and recent strategic developments.
  • Chapter 12: Supply chain—analyses upstream raw materials and suppliers, manufacturing footprint, regional production and cost, regulatory and technology, plus downstream channels and distributor roles.
  • Chapter 13: Market dynamics—explores drivers, restraints, regulatory impacts, and risk mitigation strategies.
  • Chapter 15: Actionable conclusions and strategic recommendations.
  • Why This Report:
  • Beyond standard market data, this analysis provides a clear profitability roadmap—empowering you to:
  • Allocate capital strategically to high growth regions (Chapters 6–10) and margin rich segments (Chapter 5).
  • Negotiate from strength with suppliers (Chapter 12) and customers (Chapter5) using cost and demand intelligence.
  • Outmaneuver competitors with granular insights into their operations, margins, and strategies (Chapters 3 and 11).
  • Secure your supply chain against disruptions through upstream and downstream visibility (Chapters 12 and 13).
  • Leverage this 360° intelligence to turn market complexity into actionable competitive advantage.

FAQ for this report

How fast is Sodium Iodide 131 Therapeutic Capsule Market growing?

Ans: The Sodium Iodide 131 Therapeutic Capsule Market witnessing a CAGR of 9.8% during the forecast period 2025-2031.

What is the Sodium Iodide 131 Therapeutic Capsule Market size in 2031?

Ans: The Sodium Iodide 131 Therapeutic Capsule Market size in 2031 will be US$ 271 million.

Who are the main players in the Sodium Iodide 131 Therapeutic Capsule Market report?

Ans: The main players in the Sodium Iodide 131 Therapeutic Capsule Market are ANSTO, PDRadiopharma Inc., China Isotope & Radiation Corporation (CIRC), International Isotopes Inc, Curium Pharma, Jubilant Pharmova, POLATOM（NCBJ）, NTP Radioisotopes, Isotope JSC (Rosatom)

What are the Application segmentation covered in the Sodium Iodide 131 Therapeutic Capsule Market report?

Ans: The Applications covered in the Sodium Iodide 131 Therapeutic Capsule Market report are Thyroid Cancer Treatment, Hyperthyroidism Treatment

What are the Type segmentation covered in the Sodium Iodide 131 Therapeutic Capsule Market report?

Ans: The Types covered in the Sodium Iodide 131 Therapeutic Capsule Market report are 37-7400 MBq/ Capsule, 7400MBq-/ Capsule

1 Study Coverage
1.1 Introduction to Sodium Iodide 131 Therapeutic Capsule: Definition, Properties, and Key Attributes
1.2 Market Segmentation by Type
1.2.1 Global Sodium Iodide 131 Therapeutic Capsule Market Size by Type, 2020 VS 2024 VS 2031
1.2.2 37-7400 MBq/ Capsule
1.2.3 7400MBq-/ Capsule
1.3 Market Segmentation by Application
1.3.1 Global Sodium Iodide 131 Therapeutic Capsule Market Size by Application, 2020 VS 2024 VS 2031
1.3.2 Thyroid Cancer Treatment
1.3.3 Hyperthyroidism Treatment
1.4 Assumptions and Limitations
1.5 Study Objectives
1.6 Years Considered
2 Executive Summary
2.1 Global Sodium Iodide 131 Therapeutic Capsule Revenue Estimates and Forecasts 2020-2031
2.2 Global Sodium Iodide 131 Therapeutic Capsule Revenue by Region
2.2.1 Revenue Comparison: 2020 VS 2024 VS 2031
2.2.2 Historical and Forecasted Revenue by Region (2020--2031)
2.2.3 Global Revenue Market Share by Region (2020-2031)
2.3 Global Sodium Iodide 131 Therapeutic Capsule Sales Estimates and Forecasts 2020-2031
2.4 Global Sodium Iodide 131 Therapeutic Capsule Sales by Region
2.4.1 Sales Comparison: 2020 VS 2024 VS 2031
2.4.2 Historical and Forecasted Sales by Region (2020-2031)
2.4.3 Emerging Market Focus: Growth Drivers & Investment Trends
2.4.4 Global Sales Market Share by Region (2020-2031)
3 Competition by Manufacturers
3.1 Global Sodium Iodide 131 Therapeutic Capsule Sales by Manufacturers
3.1.1 Global Sales Volume by Manufacturers (2020-2025)
3.1.2 Global Top 5 and Top 10 Manufacturers’Market Share by Sales Volume (2024)
3.2 Global Sodium Iodide 131 Therapeutic Capsule Manufacturer Revenue Rankings and Tiers
3.2.1 Global Revenue (Value) by Manufacturers (2020-2025)
3.2.2 Global Key Manufacturer Revenue Ranking (2023 vs. 2024)
3.2.3 Revenue-Based Tier Segmentation (Tier 1, Tier 2, and Tier 3)
3.3 Manufacturer Profitability Profiles and Pricing Strategies
3.3.1 Gross Margin by Top Manufacturer (2020 VS 2024)
3.3.2 Manufacturer-Level Price Trends (2020-2025)
3.4 Key Manufacturers Manufacturing Base and Headquarters
3.5 Main Product Type Market Size by Manufacturers
3.5.1 37-7400 MBq/ Capsule Market Size by Manufacturers
3.5.2 7400MBq-/ Capsule Market Size by Manufacturers
3.6 Global Sodium Iodide 131 Therapeutic Capsule Market Concentration and Dynamics
3.6.1 Global Market Concentration (CR5 and HHI)
3.6.2 Entrant/Exit Impact Analysis
3.6.3 Strategic Moves: M&A, Capacity Expansion, R&D Investment
4 Global Product Segmentation Analysis
4.1 Global Sodium Iodide 131 Therapeutic Capsule Sales Performance by Type
4.1.1 Global Historical and Forecasted Sales by Type (2020-2031)
4.1.2 Global Sales Market Share by Type (2020-2031)
4.2 Global Sodium Iodide 131 Therapeutic Capsule Revenue Trends by Type
4.2.1 Global Historical and Forecasted Revenue by Type (2020-2031)
4.2.2 Global Revenue Market Share by Type (2020-2031)
4.3 Global Average Selling Price (ASP) Trends by Type (2020-2031)
4.4 Product Technology Differentiation
4.5 Subtype Dynamics: Growth Leaders, Profitability and Risk
4.5.1 High-Growth Niches and Adoption Drivers
4.5.2 Profitability Hotspots and Cost Drivers
4.5.3 Substitution Threats
5 Global Downstream Application Analysis
5.1 Global Sodium Iodide 131 Therapeutic Capsule Sales by Application
5.1.1 Global Historical and Forecasted Sales by Application (2020-2031)
5.1.2 Global Sales Market Share by Application (2020-2031)
5.1.3 High-Growth Application Identification
5.1.4 Emerging Application Case Studies
5.2 Global Sodium Iodide 131 Therapeutic Capsule Revenue by Application
5.2.1 Global Historical and Forecasted Revenue by Application (2020-2031)
5.2.2 Revenue Market Share by Application (2020-2031)
5.3 Global Pricing Dynamics by Application (2020-2031)
5.4 Downstream Customer Analysis
5.4.1 Top Customers by Region
5.4.2 Top Customers by Application
6 North America
6.1 North America Sales Volume and Revenue (2020-2031)
6.2 North America Key Manufacturers Sales Revenue in 2024
6.3 North America Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Type (2020-2031)
6.4 North America Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Application (2020-2031)
6.5 North America Growth Accelerators and Market Barriers
6.6 North America Sodium Iodide 131 Therapeutic Capsule Market Size by Country
6.6.1 North America Revenue by Country
6.6.2 North America Sales Trends by Country
6.6.3 US
6.6.4 Canada
6.6.5 Mexico
7 Europe
7.1 Europe Sales Volume and Revenue (2020-2031)
7.2 Europe Key Manufacturers Sales Revenue in 2024
7.3 Europe Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Type (2020-2031)
7.4 Europe Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Application (2020-2031)
7.5 Europe Growth Accelerators and Market Barriers
7.6 Europe Sodium Iodide 131 Therapeutic Capsule Market Size by Country
7.6.1 Europe Revenue by Country
7.6.2 Europe Sales Trends by Country
7.6.3 Germany
7.6.4 France
7.6.5 U.K.
7.6.6 Italy
7.6.7 Russia
8 Asia-Pacific
8.1 Asia-Pacific Sales Volume and Revenue (2020-2031)
8.2 Asia-Pacific Key Manufacturers Sales Revenue in 2024
8.3 Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Type (2020-2031)
8.4 Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Application (2020-2031)
8.5 Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Market Size by Region
8.5.1 Asia-Pacific Revenue by Region
8.5.2 Asia-Pacific Sales Trends by Region
8.6 Asia-Pacific Growth Accelerators and Market Barriers
8.7 Southeast Asia
8.7.1 Southeast Asia Revenue by Country (2020 VS 2024 VS 2031)
8.7.2 Key Country Analysis: Indonesia, Vietnam, Thailand, Malaysia, Philippines
8.8 China
8.9 Japan
8.10 South Korea
8.11 China Taiwan
8.12 India
9 Central and South America
9.1 Central and South America Sales Volume and Revenue (2020-2031)
9.2 Central and South America Key Manufacturers Sales Revenue in 2024
9.3 Central and South America Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Type (2020-2031)
9.4 Central and South America Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Application (2020-2031)
9.5 Central and South America Investment Opportunities and Key Challenges
9.6 Central and South America Sodium Iodide 131 Therapeutic Capsule Market Size by Country
9.6.1 Central and South America Revenue Trends by Country (2020 VS 2024 VS 2031)
9.6.2 Brazil
9.6.3 Argentina
10 Middle East and Africa
10.1 Middle East and Africa Sales Volume and Revenue (2020-2031)
10.2 Middle East and Africa Key Manufacturers Sales Revenue in 2024
10.3 Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Type (2020-2031)
10.4 Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Sales and Revenue by Application (2020-2031)
10.5 Middle East and Africa Investment Opportunities and Key Challenges
10.6 Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Market Size by Country
10.6.1 Middle East and Africa Revenue Trends by Country (2020 VS 2024 VS 2031)
10.6.2 GCC Countries
10.6.3 Turkey
10.6.4 Egypt
10.6.5 South Africa
11 Corporate Profile
11.1 ANSTO
11.1.1 ANSTO Corporation Information
11.1.2 ANSTO Business Overview
11.1.3 ANSTO Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.1.4 ANSTO Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.1.5 ANSTO Sodium Iodide 131 Therapeutic Capsule Sales by Product in 2024
11.1.6 ANSTO Sodium Iodide 131 Therapeutic Capsule Sales by Application in 2024
11.1.7 ANSTO Sodium Iodide 131 Therapeutic Capsule Sales by Geographic Area in 2024
11.1.8 ANSTO Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
11.1.9 ANSTO Recent Developments
11.2 PDRadiopharma Inc.
11.2.1 PDRadiopharma Inc. Corporation Information
11.2.2 PDRadiopharma Inc. Business Overview
11.2.3 PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.2.4 PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.2.5 PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule Sales by Product in 2024
11.2.6 PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule Sales by Application in 2024
11.2.7 PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule Sales by Geographic Area in 2024
11.2.8 PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
11.2.9 PDRadiopharma Inc. Recent Developments
11.3 China Isotope & Radiation Corporation (CIRC)
11.3.1 China Isotope & Radiation Corporation (CIRC) Corporation Information
11.3.2 China Isotope & Radiation Corporation (CIRC) Business Overview
11.3.3 China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.3.4 China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.3.5 China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule Sales by Product in 2024
11.3.6 China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule Sales by Application in 2024
11.3.7 China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule Sales by Geographic Area in 2024
11.3.8 China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
11.3.9 China Isotope & Radiation Corporation (CIRC) Recent Developments
11.4 International Isotopes Inc
11.4.1 International Isotopes Inc Corporation Information
11.4.2 International Isotopes Inc Business Overview
11.4.3 International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.4.4 International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.4.5 International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule Sales by Product in 2024
11.4.6 International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule Sales by Application in 2024
11.4.7 International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule Sales by Geographic Area in 2024
11.4.8 International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
11.4.9 International Isotopes Inc Recent Developments
11.5 Curium Pharma
11.5.1 Curium Pharma Corporation Information
11.5.2 Curium Pharma Business Overview
11.5.3 Curium Pharma Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.5.4 Curium Pharma Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.5.5 Curium Pharma Sodium Iodide 131 Therapeutic Capsule Sales by Product in 2024
11.5.6 Curium Pharma Sodium Iodide 131 Therapeutic Capsule Sales by Application in 2024
11.5.7 Curium Pharma Sodium Iodide 131 Therapeutic Capsule Sales by Geographic Area in 2024
11.5.8 Curium Pharma Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
11.5.9 Curium Pharma Recent Developments
11.6 Jubilant Pharmova
11.6.1 Jubilant Pharmova Corporation Information
11.6.2 Jubilant Pharmova Business Overview
11.6.3 Jubilant Pharmova Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.6.4 Jubilant Pharmova Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.6.5 Jubilant Pharmova Recent Developments
11.7 POLATOM（NCBJ）
11.7.1 POLATOM（NCBJ） Corporation Information
11.7.2 POLATOM（NCBJ） Business Overview
11.7.3 POLATOM（NCBJ） Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.7.4 POLATOM（NCBJ） Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.7.5 POLATOM（NCBJ） Recent Developments
11.8 NTP Radioisotopes
11.8.1 NTP Radioisotopes Corporation Information
11.8.2 NTP Radioisotopes Business Overview
11.8.3 NTP Radioisotopes Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.8.4 NTP Radioisotopes Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.8.5 NTP Radioisotopes Recent Developments
11.9 Isotope JSC (Rosatom)
11.9.1 Isotope JSC (Rosatom) Corporation Information
11.9.2 Isotope JSC (Rosatom) Business Overview
11.9.3 Isotope JSC (Rosatom) Sodium Iodide 131 Therapeutic Capsule Product Models, Descriptions and Specifications
11.9.4 Isotope JSC (Rosatom) Sodium Iodide 131 Therapeutic Capsule Sales, Price, Revenue and Gross Margin (2020-2025)
11.9.5 Isotope JSC (Rosatom) Recent Developments
12 Value Chain and Supply-Chain Analysis
12.1 Sodium Iodide 131 Therapeutic Capsule Industry Chain
12.2 Sodium Iodide 131 Therapeutic Capsule Upstream Materials Analysis
12.2.1 Raw Materials
12.2.2 Key Suppliers Market Share & Risk Assessment
12.3 Sodium Iodide 131 Therapeutic Capsule Integrated Production Analysis
12.3.1 Manufacturing Footprint Analysis
12.3.2 Regional Production Market Share (2020-2031)
12.3.3 Regulatory and Trade Policy Impact on Production
12.3.4 Production Technology Overview
12.3.5 Regional Cost Drivers
12.4 Sodium Iodide 131 Therapeutic Capsule Sales Channels and Distribution Networks
12.4.1 Sales Channels
12.4.2 Distributors
13 Sodium Iodide 131 Therapeutic Capsule Market Dynamics
13.1 Industry Trends and Evolution
13.2 Market Growth Drivers and Emerging Opportunities
13.3 Market Challenges, Risks, and Restraints
14 Key Findings in the Global Sodium Iodide 131 Therapeutic Capsule Study
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.1.1 Research Programs/Design
15.1.1.2 Market Size Estimation
15.1.1.3 Market Breakdown and Data Triangulation
15.1.2 Data Source
15.1.2.1 Secondary Sources
15.1.2.2 Primary Sources
15.2 Author Details
FEATURED COMPANIES
ANSTO
PDRadiopharma Inc.
China Isotope & Radiation Corporation (CIRC)
International Isotopes Inc.
Curium Pharma
Jubilant Pharmova
POLATOM（NCBJ）
NTP Radioisotopes
Isotope JSC (ROSATOM)
China Isotope & Radiation Corporation (CIRC)
List of Tables
 Table 1. Global Sodium Iodide 131 Therapeutic Capsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Table 2. Global Sodium Iodide 131 Therapeutic Capsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Table 3. Global Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 4. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Region (2020-2025) & (US$ Million)
 Table 5. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Region (2026-2031) & (US$ Million)
 Table 6. Global Sodium Iodide 131 Therapeutic Capsule Sales Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (K Dose)
 Table 7. Global Sodium Iodide 131 Therapeutic Capsule Sales by Region (2020-2025) & (K Dose)
 Table 8. Global Sodium Iodide 131 Therapeutic Capsule Sales by Region (2026-2031) & (K Dose)
 Table 9. Emerging Market Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 10. Global Sodium Iodide 131 Therapeutic Capsule Sales by Manufacturers (2020-2025) & (K Dose)
 Table 11. Global Sodium Iodide 131 Therapeutic Capsule Sales Share by Manufacturers (2020-2025)
 Table 12. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Manufacturers (2020-2025) & (US$ Million)
 Table 13. Global Sodium Iodide 131 Therapeutic Capsule Revenue Market Share by Manufacturers (2020-2025)
 Table 14. Global Key Manufacturers’Ranking Shift (2023 vs. 2024) (Based on Revenue)
 Table 15. Global Sodium Iodide 131 Therapeutic Capsule by Manufacturer Tier (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Sodium Iodide 131 Therapeutic Capsule as of 2024)
 Table 16. Global Sodium Iodide 131 Therapeutic Capsule Average Gross Margin (%) by Manufacturer (2020 VS 2024)
 Table 17. Global Sodium Iodide 131 Therapeutic Capsule Average Selling Price (ASP) by Manufacturers (2020-2025) & (US$/Dose)
 Table 18. Key Manufacturers Sodium Iodide 131 Therapeutic Capsule Manufacturing Base and Headquarters
 Table 19. Global Sodium Iodide 131 Therapeutic Capsule Market Concentration Ratio (CR5 and HHI)
 Table 20. Key Market Entrant/Exit (2020-2024) – Drivers & Impact Analysis
 Table 21. Key Mergers & Acquisitions, Expansion Plans, R&D Investment
 Table 22. Global Sodium Iodide 131 Therapeutic Capsule Sales by Type (2020-2025) & (K Dose)
 Table 23. Global Sodium Iodide 131 Therapeutic Capsule Sales by Type (2026-2031) & (K Dose)
 Table 24. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Type (2020-2025) & (US$ Million)
 Table 25. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Type (2026-2031) & (US$ Million)
 Table 26. Global Sodium Iodide 131 Therapeutic Capsule ASP by Type (2020-2031) & (US$/Dose)
 Table 27. Technical Specifications by Key Product Type
 Table 28. Global Sodium Iodide 131 Therapeutic Capsule Sales by Application (2020-2025) & (K Dose)
 Table 29. Global Sodium Iodide 131 Therapeutic Capsule Sales by Application (2026-2031) & (K Dose)
 Table 30. Sodium Iodide 131 Therapeutic Capsule High-Growth Sectors Demand CAGR (2024-2031)
 Table 31. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Application (2020-2025) & (US$ Million)
 Table 32. Global Sodium Iodide 131 Therapeutic Capsule Revenue by Application (2026-2031) & (US$ Million)
 Table 33. Global Sodium Iodide 131 Therapeutic Capsule ASP by Application (2020-2031) & (US$/Dose)
 Table 34. Top Customers by Region
 Table 35. Top Customers by Application
 Table 36. North America Sodium Iodide 131 Therapeutic Capsule Growth Accelerators and Market Barriers
 Table 37. North America Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 38. North America Sodium Iodide 131 Therapeutic Capsule Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 39. Europe Sodium Iodide 131 Therapeutic Capsule Growth Accelerators and Market Barriers
 Table 40. Europe Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Country: 2020 VS 2024 VS 2031 (US$ Million)
 Table 41. Europe Sodium Iodide 131 Therapeutic Capsule Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 42. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 43. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales (K Dose) by Country (2020 VS 2024 VS 2031)
 Table 44. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Growth Accelerators and Market Barriers
 Table 45. Southeast Asia Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Table 46. Central and South America Sodium Iodide 131 Therapeutic Capsule Investment Opportunities and Key Challenges
 Table 47. Central and South America Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 48. Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Investment Opportunities and Key Challenges
 Table 49. Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Revenue Grow Rate (CAGR) by Country (2020 VS 2024 VS 2031) (US$ Million)
 Table 50. ANSTO Corporation Information
 Table 51. ANSTO Description and Major Businesses
 Table 52. ANSTO Product Models, Descriptions and Specifications
 Table 53. ANSTO Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 54. ANSTO Sales Value Proportion by Product in 2024
 Table 55. ANSTO Sales Value Proportion by Application in 2024
 Table 56. ANSTO Sales Value Proportion by Geographic Area in 2024
 Table 57. ANSTO Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
 Table 58. ANSTO Recent Developments
 Table 59. PDRadiopharma Inc. Corporation Information
 Table 60. PDRadiopharma Inc. Description and Major Businesses
 Table 61. PDRadiopharma Inc. Product Models, Descriptions and Specifications
 Table 62. PDRadiopharma Inc. Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 63. PDRadiopharma Inc. Sales Value Proportion by Product in 2024
 Table 64. PDRadiopharma Inc. Sales Value Proportion by Application in 2024
 Table 65. PDRadiopharma Inc. Sales Value Proportion by Geographic Area in 2024
 Table 66. PDRadiopharma Inc. Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
 Table 67. PDRadiopharma Inc. Recent Developments
 Table 68. China Isotope & Radiation Corporation (CIRC) Corporation Information
 Table 69. China Isotope & Radiation Corporation (CIRC) Description and Major Businesses
 Table 70. China Isotope & Radiation Corporation (CIRC) Product Models, Descriptions and Specifications
 Table 71. China Isotope & Radiation Corporation (CIRC) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 72. China Isotope & Radiation Corporation (CIRC) Sales Value Proportion by Product in 2024
 Table 73. China Isotope & Radiation Corporation (CIRC) Sales Value Proportion by Application in 2024
 Table 74. China Isotope & Radiation Corporation (CIRC) Sales Value Proportion by Geographic Area in 2024
 Table 75. China Isotope & Radiation Corporation (CIRC) Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
 Table 76. China Isotope & Radiation Corporation (CIRC) Recent Developments
 Table 77. International Isotopes Inc Corporation Information
 Table 78. International Isotopes Inc Description and Major Businesses
 Table 79. International Isotopes Inc Product Models, Descriptions and Specifications
 Table 80. International Isotopes Inc Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 81. International Isotopes Inc Sales Value Proportion by Product in 2024
 Table 82. International Isotopes Inc Sales Value Proportion by Application in 2024
 Table 83. International Isotopes Inc Sales Value Proportion by Geographic Area in 2024
 Table 84. International Isotopes Inc Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
 Table 85. International Isotopes Inc Recent Developments
 Table 86. Curium Pharma Corporation Information
 Table 87. Curium Pharma Description and Major Businesses
 Table 88. Curium Pharma Product Models, Descriptions and Specifications
 Table 89. Curium Pharma Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 90. Curium Pharma Sales Value Proportion by Product in 2024
 Table 91. Curium Pharma Sales Value Proportion by Application in 2024
 Table 92. Curium Pharma Sales Value Proportion by Geographic Area in 2024
 Table 93. Curium Pharma Sodium Iodide 131 Therapeutic Capsule SWOT Analysis
 Table 94. Curium Pharma Recent Developments
 Table 95. Jubilant Pharmova Corporation Information
 Table 96. Jubilant Pharmova Description and Major Businesses
 Table 97. Jubilant Pharmova Product Models, Descriptions and Specifications
 Table 98. Jubilant Pharmova Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 99. Jubilant Pharmova Recent Developments
 Table 100. POLATOM（NCBJ） Corporation Information
 Table 101. POLATOM（NCBJ） Description and Major Businesses
 Table 102. POLATOM（NCBJ） Product Models, Descriptions and Specifications
 Table 103. POLATOM（NCBJ） Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 104. POLATOM（NCBJ） Recent Developments
 Table 105. NTP Radioisotopes Corporation Information
 Table 106. NTP Radioisotopes Description and Major Businesses
 Table 107. NTP Radioisotopes Product Models, Descriptions and Specifications
 Table 108. NTP Radioisotopes Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 109. NTP Radioisotopes Recent Developments
 Table 110. Isotope JSC (Rosatom) Corporation Information
 Table 111. Isotope JSC (Rosatom) Description and Major Businesses
 Table 112. Isotope JSC (Rosatom) Product Models, Descriptions and Specifications
 Table 113. Isotope JSC (Rosatom) Sales (K Dose), Revenue (US$ Million), Price (US$/Dose) and Gross Margin (2020-2025)
 Table 114. Isotope JSC (Rosatom) Recent Developments
 Table 115. Key Raw Materials Distribution
 Table 116. Raw Materials Key Suppliers
 Table 117. Critical Raw Material Supplier Concentration (2024) & Risk Index
 Table 118. Milestones in Production Technology Evolution
 Table 119. Distributors List
 Table 120. Market Trends and Market Evolution
 Table 121. Market Drivers and Opportunities
 Table 122. Market Challenges, Risks, and Restraints
 Table 123. Research Programs/Design for This Report
 Table 124. Key Data Information from Secondary Sources
 Table 125. Key Data Information from Primary Sources


List of Figures
 Figure 1. Sodium Iodide 131 Therapeutic Capsule Product Picture
 Figure 2. Global Sodium Iodide 131 Therapeutic Capsule Market Size Growth Rate by Type, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 3. 37-7400 MBq/ Capsule Product Picture
 Figure 4. 7400MBq-/ Capsule Product Picture
 Figure 5. Global Sodium Iodide 131 Therapeutic Capsule Market Size Growth Rate by Application, 2020 VS 2024 VS 2031 (US$ Million)
 Figure 6. Thyroid Cancer Treatment
 Figure 7. Hyperthyroidism Treatment
 Figure 8. Sodium Iodide 131 Therapeutic Capsule Report Years Considered
 Figure 9. Global Sodium Iodide 131 Therapeutic Capsule Revenue, (US$ Million), 2020 VS 2024 VS 2031
 Figure 10. Global Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 11. Global Sodium Iodide 131 Therapeutic Capsule Revenue (CAGR) by Region: 2020 VS 2024 VS 2031 (US$ Million)
 Figure 12. Global Sodium Iodide 131 Therapeutic Capsule Revenue Market Share by Region (2020-2031)
 Figure 13. Global Sodium Iodide 131 Therapeutic Capsule Sales (2020-2031) & (K Dose)
 Figure 14. Global Sodium Iodide 131 Therapeutic Capsule Sales (CAGR) by Region (2020-2031) (K Dose)
 Figure 15. Global Sodium Iodide 131 Therapeutic Capsule Sales Market Share by Region (2020-2031)
 Figure 16. Top 5 and Top 10 Manufacturers Sodium Iodide 131 Therapeutic Capsule Sales Volume Market Share in 2024
 Figure 17. Global Sodium Iodide 131 Therapeutic Capsule Revenue Market Share Ranking (2024)
 Figure 18. Tier Distribution by Revenue Contribution (2020 VS 2024)
 Figure 19. 37-7400 MBq/ Capsule Revenue Market Share by Manufacturer in 2024
 Figure 20. 7400MBq-/ Capsule Revenue Market Share by Manufacturer in 2024
 Figure 21. Global Sodium Iodide 131 Therapeutic Capsule Sales Market Share by Type (2020-2031)
 Figure 22. Global Sodium Iodide 131 Therapeutic Capsule Revenue Market Share by Type (2020-2031)
 Figure 23. Global Sodium Iodide 131 Therapeutic Capsule Sales Market Share by Application (2020-2031)
 Figure 24. Global Sodium Iodide 131 Therapeutic Capsule Revenue Market Share by Application (2020-2031)
 Figure 25. North America Sodium Iodide 131 Therapeutic Capsule Sales YoY (2020-2031) & (K Dose)
 Figure 26. North America Sodium Iodide 131 Therapeutic Capsule Revenue YoY (2020-2031) & (US$ Million)
 Figure 27. North America Top 5 Manufacturers Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) in 2024
 Figure 28. North America Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Type (2020- 2031)
 Figure 29. North America Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Type (2020 - 2031)
 Figure 30. North America Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Application (2020-2031)
 Figure 31. North America Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 32. US Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 33. Canada Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 34. Mexico Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 35. Europe Sodium Iodide 131 Therapeutic Capsule Sales YoY (2020-2031) & (K Dose)
 Figure 36. Europe Sodium Iodide 131 Therapeutic Capsule Revenue YoY (2020-2031) & (US$ Million)
 Figure 37. Europe Top 5 Manufacturers Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) in 2024
 Figure 38. Europe Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Type (2020-2031)
 Figure 39. Europe Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 40. Europe Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Application (2020-2031)
 Figure 41. Europe Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 42. Germany Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 43. France Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 44. U.K. Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 45. Italy Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 46. Russia Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 47. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales YoY (2020-2031) & (K Dose)
 Figure 48. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Revenue YoY (2020-2031) & (US$ Million)
 Figure 49. Asia-Pacific Top 8 Manufacturers Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) in 2024
 Figure 50. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Type (2020- 2031)
 Figure 51. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Type (2020- 2031)
 Figure 52. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Application (2020-2031)
 Figure 53. Asia-Pacific Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 54. Indonesia Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 55. Japan Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 56. South Korea Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 57. China Taiwan Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 58. India Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2031) & (US$ Million)
 Figure 59. Central and South America Sodium Iodide 131 Therapeutic Capsule Sales YoY (2020-2031) & (K Dose)
 Figure 60. Central and South America Sodium Iodide 131 Therapeutic Capsule Revenue YoY (2020-2031) & (US$ Million)
 Figure 61. Central and South America Top 5 Manufacturers Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) in 2024
 Figure 62. Central and South America Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Type (2021-2031)
 Figure 63. Central and South America Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 64. Central and South America Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Application (2020-2031)
 Figure 65. Central and South America Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 66. Brazil Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2025) & (US$ Million)
 Figure 67. Argentina Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2025) & (US$ Million)
 Figure 68. Middle East, and Africa Sodium Iodide 131 Therapeutic Capsule Sales YoY (2020-2031) & (K Dose)
 Figure 69. Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Revenue YoY (2020-2031) & (US$ Million)
 Figure 70. Middle East and Africa Top 5 Manufacturers Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) in 2024
 Figure 71. Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Type (2021-2031)
 Figure 72. South America Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Type (2020-2031)
 Figure 73. Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Sales Volume (K Dose) by Application (2020-2031)
 Figure 74. Middle East and Africa Sodium Iodide 131 Therapeutic Capsule Sales Revenue (US$ Million) by Application (2020-2031)
 Figure 75. GCC Countries Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2025) & (US$ Million)
 Figure 76. Turkey Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2025) & (US$ Million)
 Figure 77. Egypt Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2025) & (US$ Million)
 Figure 78. South Africa Sodium Iodide 131 Therapeutic Capsule Revenue (2020-2025) & (US$ Million)
 Figure 79. Sodium Iodide 131 Therapeutic Capsule Industry Chain Mapping
 Figure 80. Regional Sodium Iodide 131 Therapeutic Capsule Manufacturing Base Distribution (%)
 Figure 81. Global Sodium Iodide 131 Therapeutic Capsule Production Market Share by Region (2020-2031)
 Figure 82. Sodium Iodide 131 Therapeutic Capsule Production Process
 Figure 83. Regional Sodium Iodide 131 Therapeutic Capsule Production Cost Structure
 Figure 84. Channels of Distribution (Direct Vs Distribution)
 Figure 85. Bottom-up and Top-down Approaches for This Report
 Figure 86. Data Triangulation
 Figure 87. Key Executives Interviewed
SELECT A FORMAT
Added to Cart
Electronic (PDF)

$4900

This license allows only one user to access the PDF.
Electronic (PDF)

$7350

This license allows 1 - 5 user to access the PDF, license is suitable for small groups of 5 users working together
Electronic (PDF)

$9800

This license allows users/teams in a same Enterprise to use this report, various departments within an enterpise can use this report
Add to Cart
Buy Now (15% Discount)
INQUIRE FOR DISCOUNT

HAVE A QUERY?

INQUIRE ABOUT REPORT EMAIL US

OUR CUSTOMER

Leap India

SIMILAR REPORTS

Global Sodium Iodide 131 Diagnostic Capsule Market Research Report 2024
Global Sodium Iodide 131I Therapy Capsules Market Research Report 2024
Global Sodium Iodide I 131 Kits and Capsules Market Research Report 2025
Global Sodium Iodide I131 Solutions and Capsules Market Research Report 2024
Global Kits and Iodine 131 I 131 Capsules Market Research Report 2025
Global Sodium Iodide 131I Capsules Market Research Report 2024
Global Sodium Iodide 131I Diagnostic Capsules Market Research Report 2024
Sodium Iodide 131I Oral Solution Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Iodide 131I Market Research Report 2024
Global Sodium Iodide I131 Solutions Market Research Report 2024
Sodium Iodine 131I Drugs Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Iodide Scintillator Market Research Report 2024
Global Sodium Iodide API Market Research Report 2025
Global Sodium Iodide 131I for Therapy Market Research Report 2024
Sodium Iodide Injection Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Global Sodium Iodide Powder Market Research Report 2024
Global Potassium Iodide Tablet Market Research Report 2025
Global Medical Radioactive Iodine I 131 Market Research Report 2024
Global Iodine Radioisotope Market Research Report 2024
Medical Iodine Radioisotopes Global Market Share and Ranking Overall Sales and Demand Forecast 2024 2030
Call
Buy Now
REQUEST FREE SAMPLE REPORT
Support Contacts
U.S. (TOLL FREE)
+1 (425) 388-2538
THE COMPANY
OUR PRODUCTS
CUSTOMER SUPPORT
POLICES
THE COMPANY
CUSTOMER SUPPORT
OUR PRODUCTS
POLICES
Copyright © 2018 Valuates.com. All Rights Reserved.
Sitemap - Privacy Policy - Terms & Conditions